AU2003303368B2 - Non-pegylated long-circulating liposomes - Google Patents

Non-pegylated long-circulating liposomes Download PDF

Info

Publication number
AU2003303368B2
AU2003303368B2 AU2003303368A AU2003303368A AU2003303368B2 AU 2003303368 B2 AU2003303368 B2 AU 2003303368B2 AU 2003303368 A AU2003303368 A AU 2003303368A AU 2003303368 A AU2003303368 A AU 2003303368A AU 2003303368 B2 AU2003303368 B2 AU 2003303368B2
Authority
AU
Australia
Prior art keywords
doxorubicin
liposomes
composition
liposomal
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003303368A
Other languages
English (en)
Other versions
AU2003303368A1 (en
Inventor
Gautam Vinod Daftary
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zydus BSV Pharma Pvt Ltd
Original Assignee
Zydus BSV Pharma Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zydus BSV Pharma Pvt Ltd filed Critical Zydus BSV Pharma Pvt Ltd
Publication of AU2003303368A1 publication Critical patent/AU2003303368A1/en
Assigned to BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED reassignment BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED Request for Assignment Assignors: BHARAT SERUMS AND VACCINES LIMITED
Assigned to ZYDUS BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED reassignment ZYDUS BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED Request for Assignment Assignors: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED
Application granted granted Critical
Publication of AU2003303368B2 publication Critical patent/AU2003303368B2/en
Assigned to ZYDUS BSV PHARMA PRIVATE LIMITED reassignment ZYDUS BSV PHARMA PRIVATE LIMITED Request to Amend Deed and Register Assignors: ZYDUS BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003303368A 2002-12-31 2003-12-31 Non-pegylated long-circulating liposomes Ceased AU2003303368B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1101MU2002 2002-12-31
IN1101/MUM/02 2002-12-31
PCT/IN2003/000424 WO2004058140A2 (en) 2002-12-31 2003-12-31 Non-pegylated long-circulating liposomes

Publications (2)

Publication Number Publication Date
AU2003303368A1 AU2003303368A1 (en) 2004-07-22
AU2003303368B2 true AU2003303368B2 (en) 2010-06-17

Family

ID=32500467

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303368A Ceased AU2003303368B2 (en) 2002-12-31 2003-12-31 Non-pegylated long-circulating liposomes

Country Status (18)

Country Link
EP (1) EP1435231B8 (enExample)
JP (1) JP5355842B2 (enExample)
KR (2) KR101133084B1 (enExample)
CN (1) CN1756533B (enExample)
AT (1) ATE453381T1 (enExample)
AU (1) AU2003303368B2 (enExample)
BR (1) BR0317882A (enExample)
CA (1) CA2511464C (enExample)
DE (1) DE60330745D1 (enExample)
DK (1) DK1435231T3 (enExample)
EA (1) EA008930B1 (enExample)
ES (1) ES2337563T3 (enExample)
IL (1) IL169364A (enExample)
MX (1) MXPA05007102A (enExample)
NZ (1) NZ540778A (enExample)
PT (1) PT1435231E (enExample)
WO (1) WO2004058140A2 (enExample)
ZA (1) ZA200504850B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2152312B1 (en) * 2007-05-16 2014-12-31 KTB Tumorforschungsgesellschaft mbH Low-viscous anthracycline formulation
WO2010113983A1 (ja) 2009-03-30 2010-10-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 リポソーム組成物の製造方法
PE20120923A1 (es) * 2009-03-30 2012-08-27 Eisai Randd Man Co Ltd Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo
US20130337051A1 (en) * 2011-03-01 2013-12-19 To-Bbb Holding B.V. Advanced active liposomal loading of poorly water-soluble substances
AU2015352685B2 (en) * 2014-11-25 2020-09-17 Nanobiotix Pharmaceutical composition, preparation and uses thereof
WO2017188350A1 (ja) 2016-04-28 2017-11-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍の成長を抑制する方法
MX394860B (es) * 2016-09-27 2025-03-24 Vertex Pharma Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk).
ES3075649T3 (en) 2019-07-26 2026-08-06 Eisai R&D Man Co Ltd Pharmaceutical composition for treating tumor
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN116570775B (zh) * 2023-05-16 2024-08-02 万瑞飞鸿(北京)医疗器材有限公司 一种药物涂层、血管支架及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US6132763A (en) 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ATE252372T1 (de) * 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
CA2346879A1 (en) * 1998-09-16 2000-04-27 Alza Corporation Liposome-entrapped topoisomerase inhibitors
KR20000061075A (ko) * 1999-03-23 2000-10-16 린 중친 리포솜의 응집을 방지하기 위한 방법 및 조성물
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug

Also Published As

Publication number Publication date
KR101171045B1 (ko) 2012-08-03
MXPA05007102A (es) 2005-08-26
CN1756533B (zh) 2010-06-16
EP1435231A1 (en) 2004-07-07
AU2003303368A1 (en) 2004-07-22
ATE453381T1 (de) 2010-01-15
KR20110075051A (ko) 2011-07-05
JP2006513189A (ja) 2006-04-20
IL169364A0 (en) 2007-07-04
EP1435231B8 (en) 2010-03-03
EA200500850A1 (ru) 2006-02-24
NZ540778A (en) 2008-04-30
WO2004058140A3 (en) 2004-10-28
DK1435231T3 (da) 2010-04-26
ZA200504850B (en) 2006-08-30
EP1435231B1 (en) 2009-12-30
WO2004058140B1 (en) 2004-12-16
JP5355842B2 (ja) 2013-11-27
WO2004058140A2 (en) 2004-07-15
KR20050088233A (ko) 2005-09-02
CA2511464A1 (en) 2004-07-15
DE60330745D1 (de) 2010-02-11
BR0317882A (pt) 2005-12-13
IL169364A (en) 2012-05-31
ES2337563T3 (es) 2010-04-27
PT1435231E (pt) 2010-04-08
CN1756533A (zh) 2006-04-05
EA008930B1 (ru) 2007-08-31
KR101133084B1 (ko) 2012-04-04
HK1089946A1 (en) 2006-12-15
CA2511464C (en) 2011-08-23

Similar Documents

Publication Publication Date Title
US9005655B2 (en) Non-pegylated long-circulating liposomes
Mayhew et al. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid
US6126966A (en) Liposomes containing a cisplatin compound
EP0358719B1 (en) Liposome compositions of anthracycline derivatives
AU2012297589B2 (en) Liposomal compositions
AU2024203598B2 (en) Preparation of preliposomal annamycin lyophilizate
US5560923A (en) Method of encapsulating anthracycline in liposomes
CA2511464C (en) Non-pegylated long-circulating liposomes
AU2005284909B2 (en) Delivering iron to an animal
CA3142510C (en) Preparation of preliposomal annamycin lyophilizate
HK1089946B (en) Non-pegylated long-circulating liposomes
EP1089727A1 (en) Liposomal formulations of busulphan

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED

Free format text: FORMER APPLICANT(S): BHARAT SERUMS AND VACCINES LIMITED

TC Change of applicant's name (sec. 104)

Owner name: ZYDUS BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED

Free format text: FORMER NAME: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED

FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PATENTEE TO READ ZYDUS BSV PHARMA PRIVATE LIMITED .

MK14 Patent ceased section 143(a) (annual fees not paid) or expired